Azor Tablet, Film Coated
Product Images NDC 0713-0870

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Azor (NDC 0713-0870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure (sbp) < 140 Mmhg At Week 8 With Locf (Azor 01)

A line chart depicting the percentage of subjects with systolic blood pressure (SBP) over 140 mmHg across baseline SBP values ranging from 140 to 180 mmHg. Four groups are compared: Placebo, AML 10 mg, OM 40 mg, and Azor 10/40 mg, showing decreasing percentages as baseline SBP increases, with Azor 10/40 mg consistently showing the lowest percentage.*

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure (dbp) < 90 Mmhg At Week 8 With Locf (Azor 02)

A line graph depicting the percentage of patients with diastolic blood pressure (DBP) below 90 mmHg after treatment, comparing placebo, amlodipine 10 mg, olmesartan medoxomil 40 mg, and Azor 10/40 mg. The x-axis represents baseline DBP in mmHg, and the y-axis shows the percentage of patients with DBP < 90 mmHg.*

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure (sbp) &lt; 130 Mmhg At Week 8 With Locf (Azor 03)

A line graph illustrating the percentage of patients with systolic blood pressure below 130 mmHg plotted against baseline systolic blood pressure values ranging approximately from 140 to 180 mmHg. Four groups are compared: Placebo, amlodipine 10 mg, olmesartan medoxomil 40 mg, and Azor 10/40 mg combination therapy. The Azor 10/40 mg group shows the highest percentage achieving the blood pressure goal across baseline ranges.*

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure (dbp) &lt; 80 Mmhg At Week 8 With Locf (Azor 04)

A line graph depicting the percentage of subjects with diastolic blood pressure (DBP) less than 80 mmHg plotted against baseline DBP values between 95 and 110 mmHg. The graph compares results for Placebo, Amlodipine 10 mg, Olmesartan Medoxomil 40 mg, and Azor 10/40 mg tablet groups.*

FDA Label Image

The Structural Formula For Amlodipine Besylate Is Chemically Described As 3-ethyl-5-methyl (±)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, Monobenzene (Azor 05)

Chemical structure of amlodipine besylate and olmesartan medoxomil, the active ingredients in Azor tablets.*

FDA Label Image

The Structural Formula For Olmesartan Medoxomil Is Chemically Described As 2,3-dihydroxy-2-butenyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[p-(o-1h-tetrazol-5-ylphenyl)benzyl]imidazole-5-carboxylate, C (Azor 06)

Chemical structure diagram of the active ingredient consistent with amlodipine besylate and olmesartan medoxomil, showing molecular components and bonds in the compound.*

FDA Label Image

Principal Display Panel Ndc 0713-0870-30 Azor Amlodipine And Olmesartan Medoxomil 5 mg*/ 20 mg 30 Tablets Rx Only (Azor 07)

Azor 5 mg/20 mg film-coated tablets label displaying the brand name and active ingredients amlodipine besylate and olmesartan medoxomil. The label indicates a package size of 30 tablets, marketed by Cosette Pharmaceuticals, Inc., with storage instructions and product origin noted as Germany.*

FDA Label Image

Principal Display Panel Ndc 0713-0871-30 Azor Amlodipine And Olmesartan Medoxomil 10 mg*/ 20 mg 30 Tablets Rx Only (Azor 08)

Azor 10 mg/20 mg film-coated tablets packaging label showing the product name and strength, containing 30 tablets. The label includes the active ingredients amlodipine besylate and olmesartan medoxomil, marketing information for Cosette Pharmaceuticals, Inc., and storage instructions at 25°C with permitted excursions. The product is marked as Rx only and labeled as a product of Germany.*

FDA Label Image

Principal Display Panel Ndc 0713-0872-30 Azor Amlodipine And Olmesartan Medoxomil 5 mg*/ 40 mg 30 Tablets Rx Only (Azor 09)

Azor 5 mg/40 mg film-coated tablets label showing the combination of amlodipine besylate and olmesartan medoxomil. The label indicates it contains 30 tablets and is marketed by Cosette Pharmaceuticals, Inc. Instructions note to see the package insert for dosage and use, with storage recommendations between 15 to 30°C. The product is identified as a prescription drug and is labeled as a product of Germany.*

FDA Label Image

Principal Display Panel Ndc 0713-0873-30 Azor Amlodipine And Olmesartan Medoxomil 10 mg*/ 40 mg 30 Tablets Rx Only (Azor 0a)

Label for Azor film-coated tablets containing amlodipine besylate and olmesartan medoxomil with a strength of 10 mg/40 mg. The label indicates a package size of 30 tablets, marketed by Cosette Pharmaceuticals, Inc., with storage instructions to keep at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). The label states the product is made in Germany and includes the NDC 0713-0873-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.